Real-world approaches to management of diabetic macular edema: improving durability, drying, and patient burden

In this opening segment, Dr. Maria Berrocal introduces a case-based discussion on real-world management of diabetic macular edema (DME), with a focus on improving retinal drying, extending durability, and reducing patient burden.

In this second case, Dr. Maria Berrocal presents a patient with severe, refractory diabetic macular edema (DME) who had received 13 prior anti-VEGF injections (bevacizumab and aflibercept) with persistent fluid and legal blindness (20/200 vision).

In this third case, Dr. Maria Berrocal describes a patient with highly cystic diabetic macular edema (DME) in the left eye who had shown minimal response to two prior steroid injections.